Ascentage Pharma Group International (AAPG) Assets (2023 - 2025)

Historic Assets for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $421.1 million.

  • Ascentage Pharma Group International's Assets changed N/A to $421.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.1 billion, marking a year-over-year change of. This contributed to the annual value of $364.4 million for FY2024, which is 300.41% up from last year.
  • As of Q2 2025, Ascentage Pharma Group International's Assets stood at $421.1 million.
  • In the past 5 years, Ascentage Pharma Group International's Assets ranged from a high of $421.1 million in Q2 2025 and a low of $347.3 million during Q4 2023
  • Moreover, its 3-year median value for Assets was $364.4 million (2024), whereas its average is $377.6 million.
  • Data for Ascentage Pharma Group International's Assets shows a peak YoY increase of 494.34% (in 2024) and a maximum YoY decrease of 494.34% (in 2024) over the last 5 years.
  • Ascentage Pharma Group International's Assets (Quarter) stood at $347.3 million in 2023, then grew by 4.94% to $364.4 million in 2024, then grew by 15.56% to $421.1 million in 2025.
  • Its last three reported values are $421.1 million in Q2 2025, $364.4 million for Q4 2024, and $347.3 million during Q4 2023.